MusthInsider

Latest On NantHealth, Inc (NH):

Updated on: March 18, 2021

Date/Time	Type	Description	Signal
2023-03-06 17:18 EST	News	NantHealth to receive $22.5M in new financing from Highbridge and Nant Capital	N/A
2022-12-15 13:28 EST	News	NantHealth executes 1-for-15 reverse stock split	N/A
2022-11-06 12:07 EST	News	NantHealth, Inc. (NH) Q3 2022 Earnings Call Transcript	N/A
2022-11-04 06:11 EST	News	NantHealth Non-GAAP EPS of -$0.12, revenue of $16.6M	N/A
2022-08-07 04:24 EST	News	NantHealth, Inc. (NH) Management on Q2 2022 Results - Earnings Call Transcript	N/A
2022-08-05 05:55 EST	News	NantHealth GAAP EPS of -$0.11, revenue of $16.5M	N/A
2022-05-08 20:05 EST	News	NantHealth's (NH) Management on Q1 2022 Results - Earnings Call Transcript	N/A
2022-05-06 05:46 EST	News	NantHealth Non-GAAP EPS of -$0.11 misses by $0.02, revenue of $16.37M misses by $0.06M	N/A
2022-02-27 20:45 EST	News	NantHealth, Inc. (NH) Q4 2021 Results - Earnings Call Transcript	N/A
2022-02-25 12:00 EST	News	NantHealth Non-GAAP EPS of -$0.10 misses by $0.01, revenue of $16M in-line	N/A
2022-02-23 23:06 EST	News	NantHealth Q4 2021 Earnings Preview	N/A
2021-11-05 10:44 EST	News	NantHealth EPS misses by $0.02, misses on revenue	N/A
2021-11-02 01:12 EST	News	Warning: NH is at high risk of performing badly	N/A
2021-08-06 07:47 EST	News	NantHealth, Inc. (NH) Management on Q2 2021 Results - Earnings Call Transcript	N/A
2021-08-03 15:47 EST	News	NantHealth picks internal candidate for medical chief	N/A
2021-04-14 11:31 EST	News	NantHealth to issue $137.5M of senior unsecured convertible notes due 2026	N/A
2021-03-01 16:02 EST	Earnings Estimate	An EPS average of -$0.06 is estimated for the quarter ending on June 30, 2021.	N/A
2021-03-01 16:02 EST	Earnings Estimate	An EPS average of -$0.17 is estimated for the 2022 year.	Sell
2021-02-27 16:42 EST	News	NantHealth, Inc. (NH) Q4 2020 Results - Earnings Call Transcript	N/A
2021-02-27 00:17 EST	Financials	Company financials have been released.	Neutral
2021-01-25 20:17 EST	News	NantHealth and Sesame sign deal to offer patients direct access to affordable care	N/A
2020-12-12 03:05 EST	News	NantHealth jumps after study highlights the utility of its decision-support platform	N/A
2020-11-26 20:57 EST	Financials	Company financials have been released.	Neutral
2020-11-12 04:46 EST	Analyst Rating	The Analyst Target Price has decreased from $4.25 to $3.75.	Neutral
2020-11-11 04:32 EST	Financials	Company financials have been released.	Neutral
2020-11-09 04:41 EST	Financials	Company financials have been released.	Neutral
2020-11-09 04:41 EST	Earnings Estimate	An EPS average of -$0.05 is estimated for the quarter ending on March 31, 2021.	Buy
2020-11-08 11:32 EST	News	NantHealth, Inc. (NH) Q3 2020 Results - Earnings Call Transcript	N/A
2020-11-08 00:19 EST	Financials	Company financials have been released.	Neutral
2020-11-07 16:36 EST	Financials	Company financials have been released.	Neutral
2020-11-06 14:54 EST	News	NantHealth EPS in-line, beats on revenue	N/A
2020-09-26 13:31 EST	Financials	Company financials have been released.	Neutral
2020-09-17 05:38 EST	Financials	Company financials have been released.	Neutral
2020-08-14 09:35 EST	Financials	Company financials have been released.	Neutral
2020-08-11 21:28 EST	Analyst Rating	The Analyst Target Price has increased from $3.3 to $4.25.	Buy
2020-08-11 01:22 EST	Financials	Company financials have been released.	Neutral
2020-08-09 19:48 EST	News	NantHealth, Inc. (NH) Q2 2020 Results - Earnings Call Transcript	N/A
2020-08-08 01:21 EST	Financials	Company financials have been released.	Neutral
2020-08-06 23:04 EST	News	NantHealth EPS misses by $0.01, misses on revenue	N/A
2020-08-06 21:25 EST	Financials	Company financials have been released.	Neutral
2020-08-06 13:21 EST	Financials	Company financials have been released.	Neutral
2020-07-31 01:48 EST	Financials	Company financials have been released.	Neutral
2020-07-30 05:16 EST	Financials	Company financials have been released.	Neutral
2020-07-27 13:13 EST	Financials	Company financials have been released.	Neutral
2020-07-23 17:52 EST	Financials	Company financials have been released.	Neutral
2020-07-10 19:29 EST	News	NantHealth Points To The Future Of Healthcare	N/A
2020-07-09 09:28 EST	Financials	Company financials have been released.	Neutral
2020-07-01 17:16 EST	Financials	Company financials have been released.	Neutral
2020-06-26 09:28 EST	Financials	Company financials have been released.	Neutral
2020-06-14 05:11 EST	Financials	Company financials have been released.	Neutral

About NantHealth, Inc (NH):

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers GPS Cancer, a comprehensive molecular profile that integrates whole genome/exome (DNA) sequencing of tumor and normal germline samples and whole transcriptome (RNA) sequencing; Omics Core, an in-vitro diagnostic built on a custom-targeted whole exome sequencing platform; and Quadris, a data solution that includes multi-data analysis, reporting, and professional service. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

See Advanced Chart

General

Name NantHealth, Inc
Symbol NH
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryHealth Information Services
Full Time Employees 352
Fiscal Year EndDecember
IPO Date2016-06-02
Gic SectorHealth Care
Gic GroupHealth Care Equipment & Services
Gic IndustryHealth Care Technology
Gic SubIndustryHealth Care Technology
Web URLhttp://nanthealth.com

Valuation

Price/Sales (Trailing 12 Mt.) 5.67
Enterprise Value Revenue 8.43

Financials

Most Recent Quarter 2020-12-31
Current Year EPS Estimate -$0.29
Next Year EPS Estimate -$0.21
Next Quarter EPS Estimate -$0.07
Profit Margin -77%
Operating Margin -35%
Return on Assets -7%
Revenue 73.17 million
Earnings Per Share -$1.65
Revenue Per Share $0.66
Gross Profit 48.7 million
Quarterly Earnings Growth 0.4%

Highlights

Market Capitalization 401.86 million
EBITDA -27742000
Analyst Target Price $3.75
Book Value Per Share -$0.28

Share Statistics

Shares Outstanding 111.32 million
Shares Float 27.46 million
% Held by Insiders 5962%
% Held by Institutions 21.64%
Shares Short 1.81 million
Shares Short Prior Month 1.86 million
Short Ratio 2.3
Short % of Float 7%
Short % of Shares Outstanding 2%

Technicals

Beta 1.75
52 Week High $6.39
52 Week Low $1.18
50 Day Moving Average 4.16
200 Day Moving Average 3.07

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

NantHealth, Inc (NH) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

NantHealth, Inc (NH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-12-31	2021-02-25	$N/A	-$0.06	-$0.08	25%
2020-09-30	2020-11-05	$N/A	-$0.07	-$0.07	-7.69%
2020-06-30	2020-08-06	$N/A	-$0.07	-$0.06	-27.27%
2020-03-31	2020-05-07	$18.18 million	-$0.06	-$0.07	7.69%
2019-12-31	2020-02-28	$24.19 million	-$0.04	-$0.06	27.27%
2019-09-30	2019-11-07	$22.36 million	-$0.07	-$0.04	-100%
2019-06-30	2019-08-08	$25.69 million	-$0.04	-$0.09	55.56%
2019-03-31	2019-05-09	$23.73 million	-$0.10	-$0.10	0%
2018-12-31	2019-03-28	$22.86 million	-$0.08	-$0.09	11.11%
2018-09-30	2018-11-15	$22.29 million	-$0.10	-$0.13	20%
2018-06-30	2018-08-09	$22.05 million	-$0.10	-$0.11	9.09%
2018-03-31	2018-05-09	$22.26 million	-$0.12	-$0.12	-4.35%
2017-12-31	2018-03-14	$22.3 million	-$0.07	-$0.14	51.15%
2017-09-30	2017-11-09	$21.76 million	-$0.13	-$0.14	3.7%
2017-06-30	2017-08-10	$23.51 million	-$0.18	-$0.16	-10.77%
2017-03-31	2017-05-10	$19.1 million	-$0.24	-$0.20	-23.08%
2016-12-31	2017-03-30	$17.85 million	-$0.18	-$0.19	6.1%
2016-09-30	2016-11-07	$20.66 million	-$0.18	-$0.21	15.09%
2016-06-30	2016-08-09	$22.45 million	-$0.15	-$0.41	63.19%

NantHealth, Inc (NH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date	Dec 31 2020	Sep 30 2020	Jun 30 2020	Mar 31 2020	Dec 31 2019
Research Development	N/A	N/A	N/A	3.55 million	4.84 million
Income Before Tax	N/A	N/A	N/A	-8.85 million	-11.69 million
Selling General Administrative	N/A	N/A	N/A	12.43 million	13.94 million
Gross Profit	N/A	N/A	N/A	10.98 million	15.25 million
Ebit	N/A	N/A	N/A	81000	-4.59 million
Operating Income	N/A	N/A	N/A	-5.86 million	-4.59 million
Income Tax Expense	273000	77000	4000	93000	56000
Total Revenue	N/A	N/A	N/A	18.18 million	24.19 million
Cost of Revenue	N/A	N/A	N/A	7.2 million	8.94 million
Total Other Income Expense Net	N/A	N/A	N/A	1.67 million	-7.1 million
Net Income From Continuing Operations	N/A	N/A	N/A	-8.94 million	-11.75 million
Net Income Applicable to Common Shares	-20.1 million	-11 million	-48.29 million	23.07 million	-11.75 million

Cash Flow:

Date	Sep 30 2020	Jun 30 2020	Mar 31 2020	Dec 31 2019	Sep 30 2019
Investments	-7.6 million	N/A	N/A	N/A	N/A
Change to Liabilities	N/A	N/A	N/A	N/A	N/A
Total Cash Flow from Investing Activities	N/A	N/A	N/A	N/A	N/A
Net Borrowings	N/A	N/A	N/A	N/A	N/A
Total Cash Flow from Financial Activities	1.22 million	N/A	N/A	N/A	N/A
Change to Operating Activities	N/A	N/A	N/A	N/A	N/A
Change in Cash	-11.62 million	N/A	N/A	N/A	N/A
Total Cash from Operating Activities	-5.25 million	N/A	N/A	N/A	N/A
Depreciation	4.3 million	N/A	N/A	N/A	N/A
Other Cash Flow from Investing Activities	N/A	N/A	N/A	N/A	N/A
Change to Inventory	N/A	N/A	N/A	N/A	N/A
Change to Account Receivables	-286000	N/A	N/A	N/A	N/A
Other Cash Flow from Financing Activities	N/A	N/A	N/A	N/A	N/A
Change to Net Income	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	2.12 million	N/A	N/A	N/A	N/A

Balance Sheet:

Date	Dec 31 2020	Sep 30 2020	Jun 30 2020	Mar 31 2020	Dec 31 2019
Total Liabailities	N/A	N/A	N/A	294.55 million	323.62 million
Total Stockholder Equity	N/A	N/A	N/A	-33.59 million	-57.14 million
Other Current Liabilities	5.4 million	7.88 million	N/A	N/A	20.87 million
Total Assets	N/A	N/A	N/A	260.96 million	266.49 million
Common Stock	11000	11000	11000	11000	11000
Other Current Assets	N/A	N/A	N/A	882000	N/A
Retained Earnings	-1 billion	-983.11 million	-972.11 million	-923.82 million	-946.88 million
Other Liabilities	66.09 million	55.91 million	55.24 million	47.14 million	48.93 million
Other Assets	2.75 million	2.47 million	2.89 million	3.42 million	2.93 million
Cash	N/A	N/A	N/A	47.48 million	5.24 million
Total Current Liabilities	124.76 million	25.93 million	N/A	30.42 million	57.5 million
Other Stockholder Equity	-168000	-283000	-416000	-406000	-218000
Property, Plant & Equipment	20.64 million	21.84 million	20.98 million	21.85 million	26.17 million
Total Current Assets	30.6 million	36.14 million	N/A	58.63 million	37.91 million
Long Term Investments	N/A	N/A	N/A	29.92 million	31.7 million
Net Tangible Assets	-258.09 million	-241.33 million	-227.36 million	-180.74 million	-224.91 million
Short Term Investments	N/A	N/A	N/A	N/A	N/A
Long Term Debt	N/A	N/A	N/A	207.72 million	206.18 million
Inventory	N/A	N/A	N/A	N/A	798000
Accounts Payable	5.12 million	2.15 million	N/A	3.31 million	3.95 million

NantHealth, Inc (NH) Chart:

NantHealth, Inc (NH) News:

Below you will find a list of latest news for NantHealth, Inc (NH) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

NantHealth, Inc (NH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent

Latest NH Trades:

Date	Shares	Price
Jun 13, 2022 7:57 PM EST	100	$0.545
Jun 13, 2022 7:58 PM EST	100	$0.5447
Jun 13, 2022 7:58 PM EST	44	$0.5447
Jun 13, 2022 7:58 PM EST	3	$0.54
Jun 13, 2022 7:59 PM EST	24	$0.5416

NantHealth, Inc (NH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date	Form Type	Form Name	Link
2020-06-19	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1566469/000156646920000032/0001566469-20-000032-index.htm
2017-08-09	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1566469/000000000017028146/0000000000-17-028146-index.htm
2018-03-26	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1566469/000000000018009095/0000000000-18-009095-index.htm
2017-08-25	3/A	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924317021040/0000899243-17-021040-index.htm
2017-08-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924317021042/0000899243-17-021042-index.htm
2017-10-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924317023695/0000899243-17-023695-index.htm
2017-10-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924317023972/0000899243-17-023972-index.htm
2017-11-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924317025608/0000899243-17-025608-index.htm
2017-11-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924317025615/0000899243-17-025615-index.htm
2017-11-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924317025617/0000899243-17-025617-index.htm
2017-11-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924317025619/0000899243-17-025619-index.htm
2017-12-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924317028187/0000899243-17-028187-index.htm
2018-01-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318000825/0000899243-18-000825-index.htm
2018-02-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318003102/0000899243-18-003102-index.htm
2018-03-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318006835/0000899243-18-006835-index.htm
2018-04-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318009869/0000899243-18-009869-index.htm
2018-05-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318011409/0000899243-18-011409-index.htm
2018-05-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318011410/0000899243-18-011410-index.htm
2018-05-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318011837/0000899243-18-011837-index.htm
2018-06-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318015564/0000899243-18-015564-index.htm
2018-06-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318015994/0000899243-18-015994-index.htm
2018-07-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318019699/0000899243-18-019699-index.htm
2018-08-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318021603/0000899243-18-021603-index.htm
2018-09-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318024008/0000899243-18-024008-index.htm
2018-09-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318024009/0000899243-18-024009-index.htm
2018-09-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318024013/0000899243-18-024013-index.htm
2018-09-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318024014/0000899243-18-024014-index.htm
2018-09-20	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318024913/0000899243-18-024913-index.htm
2018-10-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924318026470/0000899243-18-026470-index.htm
2019-05-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924319012058/0000899243-19-012058-index.htm
2019-06-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924319017240/0000899243-19-017240-index.htm
2019-06-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924319017241/0000899243-19-017241-index.htm
2019-06-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924319017243/0000899243-19-017243-index.htm
2019-08-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924319021724/0000899243-19-021724-index.htm
2019-08-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924319021726/0000899243-19-021726-index.htm
2019-11-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924319026921/0000899243-19-026921-index.htm
2020-03-13	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924320008304/0000899243-20-008304-index.htm
2020-03-13	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924320008306/0000899243-20-008306-index.htm
2020-05-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924320012104/0000899243-20-012104-index.htm
2020-05-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924320014193/0000899243-20-014193-index.htm
2020-05-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924320014199/0000899243-20-014199-index.htm
2020-05-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924320014203/0000899243-20-014203-index.htm
2020-08-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924320023104/0000899243-20-023104-index.htm
2020-08-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1566469/000089924320023105/0000899243-20-023105-index.htm
2017-08-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000119312517252742/0001193125-17-252742-index.htm
2018-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1566469/000119312518045791/0001193125-18-045791-index.htm
2018-03-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000119312518077306/0001193125-18-077306-index.htm
2018-03-16	S-3	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1566469/000119312518086060/0001193125-18-086060-index.htm
2018-04-02	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1566469/000119312518104529/0001193125-18-104529-index.htm
2018-04-30	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1566469/000119312518143057/0001193125-18-143057-index.htm
2018-06-11	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000119312518189508/0001193125-18-189508-index.htm
2018-06-15	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1566469/000119312518194503/0001193125-18-194503-index.htm
2018-07-11	10-Q/A	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1566469/000119312518216117/0001193125-18-216117-index.htm
2018-08-23	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000119312518256401/0001193125-18-256401-index.htm
2018-09-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000119312518271335/0001193125-18-271335-index.htm
2019-04-30	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1566469/000119312519129241/0001193125-19-129241-index.htm
2020-04-21	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1566469/000119312520112644/0001193125-20-112644-index.htm
2017-07-31	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1566469/000156646917000021/0001566469-17-000021-index.htm
2017-08-10	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646917000024/0001566469-17-000024-index.htm
2017-08-11	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1566469/000156646917000027/0001566469-17-000027-index.htm
2017-08-31	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646917000031/0001566469-17-000031-index.htm
2017-11-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646917000035/0001566469-17-000035-index.htm
2017-11-14	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1566469/000156646917000038/0001566469-17-000038-index.htm
2018-03-14	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646918000003/0001566469-18-000003-index.htm
2018-03-16	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1566469/000156646918000006/0001566469-18-000006-index.htm
2018-05-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646918000008/0001566469-18-000008-index.htm
2018-05-10	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1566469/000156646918000010/0001566469-18-000010-index.htm
2018-08-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646918000014/0001566469-18-000014-index.htm
2018-08-09	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1566469/000156646918000017/0001566469-18-000017-index.htm
2018-11-15	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646918000022/0001566469-18-000022-index.htm
2018-11-21	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1566469/000156646918000026/0001566469-18-000026-index.htm
2019-01-18	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646919000003/0001566469-19-000003-index.htm
2019-03-18	NT 10-K	Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405	https://www.sec.gov/Archives/edgar/data/1566469/000156646919000006/0001566469-19-000006-index.htm
2019-03-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646919000009/0001566469-19-000009-index.htm
2019-04-01	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1566469/000156646919000012/0001566469-19-000012-index.htm
2019-04-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646919000015/0001566469-19-000015-index.htm
2019-05-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646919000021/0001566469-19-000021-index.htm
2019-05-09	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1566469/000156646919000023/0001566469-19-000023-index.htm
2019-05-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646919000024/0001566469-19-000024-index.htm
2019-05-31	SD		https://www.sec.gov/Archives/edgar/data/1566469/000156646919000028/0001566469-19-000028-index.htm
2019-06-18	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646919000031/0001566469-19-000031-index.htm
2019-06-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646919000034/0001566469-19-000034-index.htm
2019-08-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646919000040/0001566469-19-000040-index.htm
2019-08-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1566469/000156646919000042/0001566469-19-000042-index.htm
2019-08-13	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646919000045/0001566469-19-000045-index.htm
2019-11-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646919000050/0001566469-19-000050-index.htm
2019-11-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1566469/000156646919000054/0001566469-19-000054-index.htm
2019-11-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646919000055/0001566469-19-000055-index.htm
2020-01-14	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646920000004/0001566469-20-000004-index.htm
2020-02-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646920000006/0001566469-20-000006-index.htm
2020-02-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646920000013/0001566469-20-000013-index.htm
2020-02-28	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1566469/000156646920000015/0001566469-20-000015-index.htm
2020-03-16	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646920000017/0001566469-20-000017-index.htm
2020-05-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646920000021/0001566469-20-000021-index.htm
2020-05-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1566469/000156646920000023/0001566469-20-000023-index.htm
2020-05-22	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646920000025/0001566469-20-000025-index.htm
2020-05-29	SD		https://www.sec.gov/Archives/edgar/data/1566469/000156646920000028/0001566469-20-000028-index.htm
2020-06-19	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1566469/000156646920000032/0001566469-20-000032-index.htm
2020-07-27	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646920000035/0001566469-20-000035-index.htm
2020-08-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646920000039/0001566469-20-000039-index.htm
2020-08-10	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1566469/000156646920000042/0001566469-20-000042-index.htm
2020-11-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1566469/000156646920000048/0001566469-20-000048-index.htm
2018-04-04	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1566469/999999999518000756/9999999995-18-000756-index.htm
2018-03-23	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1566469/999999999718003638/9999999997-18-003638-index.htm

NantHealth, Inc (NH) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of NantHealth, Inc (NH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 5962%
Institutional Ownership: 2164%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2017-10-06	Ronald Allen Louks	Chief Operating Officer	Sell	26,820.00	4.28	114,789.60	0.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924317023972/0000899243-17-023972-index.htm
2017-11-06	Ronald Allen Louks	Chief Operating Officer	Buy	10,000.00			10,000.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924317025619/0000899243-17-025619-index.htm
2017-11-06	Ronald Allen Louks	Chief Operating Officer	Buy	125,196.00			131,901.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924317025619/0000899243-17-025619-index.htm
2018-09-06	KIRK K CALHOUN	Director	Buy	52,910.00			148,780.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318024008/0000899243-18-024008-index.htm
2018-09-06	MICHAEL D BLASZYK	Director	Buy	52,910.00			148,780.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318024013/0000899243-18-024013-index.htm
2018-09-06	MICHAEL S SITRICK	Director	Buy	52,910.00			148,780.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318024014/0000899243-18-024014-index.htm
2018-05-06	Ronald Allen Louks	Chief Operating Officer	Sell	7,005.00	3.41	23,887.05	167,391.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318011837/0000899243-18-011837-index.htm
2018-06-06	Ronald Allen Louks	Chief Operating Officer	Sell	5,604.00	3.49	19,557.96	167,391.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318015564/0000899243-18-015564-index.htm
2018-07-06	Ronald Allen Louks	Chief Operating Officer	Sell	5,749.00	3.54	20,351.46	167,391.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318019699/0000899243-18-019699-index.htm
2018-08-06	Ronald Allen Louks	Chief Operating Officer	Sell	6,304.00	3.15	19,857.60	167,391.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318021603/0000899243-18-021603-index.htm
2018-09-06	Ronald Allen Louks	Officer	Sell	6,305.00	1.89	11,916.45	167,391.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318024009/0000899243-18-024009-index.htm
2018-10-06	Ronald Allen Louks	Officer	Sell	6,304.00	1.42	8,951.68	167,391.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318026470/0000899243-18-026470-index.htm
2018-05-06	Ronald Allen Louks	Chief Operating Officer	Buy	10,000.00			177,391.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318011837/0000899243-18-011837-index.htm
2018-06-06	Ronald Allen Louks	Chief Operating Officer	Buy	10,000.00			177,391.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318015564/0000899243-18-015564-index.htm
2018-07-06	Ronald Allen Louks	Chief Operating Officer	Buy	10,000.00			177,391.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318019699/0000899243-18-019699-index.htm
2018-08-06	Ronald Allen Louks	Chief Operating Officer	Buy	10,000.00			177,391.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318021603/0000899243-18-021603-index.htm
2018-09-06	Ronald Allen Louks	Officer	Buy	10,000.00			177,391.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318024009/0000899243-18-024009-index.htm
2018-10-06	Ronald Allen Louks	Officer	Buy	10,000.00			177,391.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318026470/0000899243-18-026470-index.htm
2020-03-11	Deanna L. Wise	Director	Buy	179,558.00			179,558.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924320008306/0000899243-20-008306-index.htm
2018-05-01	Ronald Allen Louks	Chief Operating Officer	Buy	125,196.00			204,886.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318011409/0000899243-18-011409-index.htm
2019-05-01	Ronald Allen Louks	Chief Operating Officer	Buy	125,196.00			292,587.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924319012058/0000899243-19-012058-index.htm
2020-05-01	Ronald Allen Louks	Chief Operating Officer	Buy	125,195.00			361,818.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924320012104/0000899243-20-012104-index.htm
2017-10-06	Ronald Allen Louks	Chief Operating Officer	Buy	40,000.00			40,000.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924317023972/0000899243-17-023972-index.htm
2017-05-01	PAUL HOLT	Chief Financial Officer	Buy	3,974.00			45,474.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924317021042/0000899243-17-021042-index.htm
2017-11-06	KIRK K CALHOUN	Director	Buy	50,868.00			50,868.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924317025615/0000899243-17-025615-index.htm
2017-11-06	MICHAEL D BLASZYK	Director	Buy	50,868.00			50,868.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924317025617/0000899243-17-025617-index.htm
2017-11-06	MICHAEL S SITRICK	Director	Buy	50,868.00			50,868.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924317025608/0000899243-17-025608-index.htm
2018-05-01	PAUL HOLT	Chief Financial Officer	Buy	3,974.00			56,822.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318011410/0000899243-18-011410-index.htm
2017-06-07	PAUL HOLT	Chief Financial Officer	Buy	14,207.00			58,187.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924317021042/0000899243-17-021042-index.htm
2018-06-07	PAUL HOLT	Chief Financial Officer	Buy	14,207.00			69,655.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318015994/0000899243-18-015994-index.htm
2017-11-06	Ronald Allen Louks	Chief Operating Officer	Sell	6,705.00	3.39	22,729.95	79,690.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924317025619/0000899243-17-025619-index.htm
2017-12-06	Ronald Allen Louks	Chief Operating Officer	Sell	5,245.00	3.03	15,892.35	79,690.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924317028187/0000899243-17-028187-index.htm
2018-01-08	Ronald Allen Louks	Chief Operating Officer	Sell	6,175.00	3.52	21,736.00	79,690.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318000825/0000899243-18-000825-index.htm
2018-02-06	Ronald Allen Louks	Chief Operating Officer	Sell	6,475.00	3.02	19,554.50	79,690.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318003102/0000899243-18-003102-index.htm
2018-03-06	Ronald Allen Louks	Chief Operating Officer	Sell	7,095.00	3.56	25,258.20	79,690.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318006835/0000899243-18-006835-index.htm
2018-04-06	Ronald Allen Louks	Chief Operating Officer	Sell	7,005.00	3.04	21,295.20	79,690.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318009869/0000899243-18-009869-index.htm
2017-12-06	Ronald Allen Louks	Chief Operating Officer	Buy	10,000.00			89,690.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924317028187/0000899243-17-028187-index.htm
2018-01-08	Ronald Allen Louks	Chief Operating Officer	Buy	10,000.00			89,690.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318000825/0000899243-18-000825-index.htm
2018-02-06	Ronald Allen Louks	Chief Operating Officer	Buy	10,000.00			89,690.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318003102/0000899243-18-003102-index.htm
2018-03-06	Ronald Allen Louks	Chief Operating Officer	Buy	10,000.00			89,690.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318006835/0000899243-18-006835-index.htm
2018-04-06	Ronald Allen Louks	Chief Operating Officer	Buy	10,000.00			89,690.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318009869/0000899243-18-009869-index.htm
2018-09-06	KIRK K CALHOUN	Director	Buy	45,002.00			95,870.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318024008/0000899243-18-024008-index.htm
2018-09-06	MICHAEL D BLASZYK	Director	Buy	45,002.00			95,870.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318024013/0000899243-18-024013-index.htm
2018-09-06	MICHAEL S SITRICK	Director	Buy	45,002.00			95,870.00	https://www.sec.gov/Archives/edgar/data/1566469/000089924318024014/0000899243-18-024014-index.htm

NantHealth, Inc

(NASDAQ:NH)